Alzheimer's Drugs - Search News

Novo Nordisk’s oral GLP-1 drug didn’t work on Alzheimer’s

· 18h · on MSN

Weight-Loss Drugs Don’t Appear to Work Against Alzheimer’s

GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the drugs affect the body beyond just weight loss. But one of the more anticipated studies exploring how they impact Alzheimer’s disease has found no meaningful effect, Novo Nordisk said in a press release on Nov. 24

Continue reading

· 19h · on MSN

Novo Nordisk Alzheimer's drug trials fail in blow to weight-loss giant

· 19h · on MSN

Novo Nordisk’s oral GLP-1 drug didn’t work on Alzheimer’s as hoped, but don’t call it a failure

MedPage Today on MSN

Highly Anticipated Alzheimer's Trials Yield Disappointing Results for GLP-1 Drug

The biomarker improvements in the EVOKE studies are worth noting, observed Howard Fillit, MD, of the Alzheimer's Drug ...

8h

Ozempic Pill Flops in Major Trials for Alzheimer’s

An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo.

18hon MSN

Analysts, investors say Alzheimer's miss adds to Novo's challenges, but fundamentals intact

Novo Nordisk said on Monday that two late-stage trials testing an older oral version of its semaglutide drug failed to meet ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results